NICS-UK leads the way in cardiology diagnostics as UK distributor of smartphone-connected 7-day ECG technology

NICS-UK today announced the launch of a next-generation, smartphone-connected 7-day ECG monitoring system as a first in the United Kingdom - marking a significant advancement in extended cardiac diagnostics.

NICS-UK is brings advanced wearable cardiac monitoring solutions and diagnostics to healthcare providers nationwide. The system integrates 2-channel biosensor technology developed by LifeSignals with the UbiqVue™ Holter software platform, enabling a fully connected, end-to-end cardiac monitoring workflow.

This positions NICS-UK at the forefront of delivering scalable, technology-enabled cardiology diagnostics - supporting hospital systems, cardiology practices and other healthcare partners. The introduction of this extended wear ECG device reflects the organisation’s commitment to delivering modern cardiology advancements and high yield cardiac diagnostics to healthcare partners across the UK, ensuring that patients receive timely and effective diagnoses.

The extended-wear ECG solution enables continuous monitoring of heart activity for up to seven days, capturing a comprehensive dataset across the full wear period. Evidence from long-duration monitoring studies shows that extended recording significantly increases arrhythmia detection rates while reducing the need for repeat testing- supporting faster, more confident clinical decision-making.
The system’s cloud-connected infrastructure allows for same-day data upload and analysis, giving cardiologists immediate access to complete datasets once monitoring is complete -without requiring patients to return devices.

Designed for real-world use, the lightweight, single-use biosensor supports high patient compliance and can be worn comfortably during normal daily activities, including sleep and showering. The smartphone-enabled workflow removes the need for in-clinic fitting and device return, reducing administrative burden and accelerating the diagnostic pathway. A mail-back option remains available to ensure accessibility for all patients.

NICS-UK can offer flexible deployment models in conjunction with UltraGreen Cardiac Technologies - ranging from direct device supply to fully integrated service solutions combining hardware, cloud-based software and clinical workflow support.

The technology also supports scalable deployment, enabling NICS-UK and its healthcare partners to increase patient throughput without device limitations - aligning with national priorities to reduce diagnostic backlogs and improve access to timely cardiac assessment.

“This innovative device aligns with our mission to enhance patient care through advanced technology,” said Dennis Wait, MD of NICS UK. “By being the first to offer the smartphone connected 7 Day ECG in the UK, we are empowering our patients with accessible cardiac monitoring while supporting cardiologists with detailed insights into their patients’ heart health.”

NICS‑UK’s adoption of this extended‑wear, cloud‑connected ECG technology reinforces its position as a leader in modern cardiology diagnostics. The organisation remains committed to deploying secure, scalable tools that improve diagnostic yield, streamline workflows, and deliver a better experience for both patients and clinicians.